Published in Neuropediatrics on June 01, 2005
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis (2010) 1.34
Lysosomal storage disorders in the newborn. Pediatrics (2009) 1.29
Multi-system disorders of glycosphingolipid and ganglioside metabolism. J Lipid Res (2010) 1.22
Glucosylceramide transfer from lysosomes--the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data. J Inherit Metab Dis (2006) 1.01
Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion. Mol Cancer (2010) 1.00
GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci U S A (2013) 0.99
Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations. Am J Med Genet A (2009) 0.98
The protective role of prosaposin and its receptors in the nervous system. Brain Res (2014) 0.94
Serum prosaposin levels are increased in patients with advanced prostate cancer. Prostate (2011) 0.86
Neurolysosomal pathology in human prosaposin deficiency suggests essential neurotrophic function of prosaposin. Acta Neuropathol (2006) 0.83
Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice. Hum Mol Genet (2013) 0.79
Regional expression of prosaposin in the wild-type and saposin D-deficient mouse brain detected by an anti-mouse prosaposin-specific antibody. Proc Jpn Acad Ser B Phys Biol Sci (2009) 0.76
Differentially expressed proteins underlying childhood cortical dysplasia with epilepsy identified by iTRAQ proteomic profiling. PLoS One (2017) 0.75
Deciphering alternative splicing and nonsense-mediated decay modulate expression in primary lymphoid tissues of birds infected with avian pathogenic E. coli (APEC). BMC Genet (2017) 0.75
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet (2000) 4.27
Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem (1971) 2.11
Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int (2006) 1.65
Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol (1990) 1.62
Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell (1997) 1.47
Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies. J Nucl Med (1993) 1.44
Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med (1990) 1.43
Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol (1999) 1.43
Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med (1990) 1.42
Eight novel ABCD1 gene mutations and three polymorphisms in patients with X-linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange. Hum Mutat (2001) 1.38
Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis (2005) 1.36
Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am J Hum Genet (2001) 1.34
A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate. J Inherit Metab Dis (2005) 1.33
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab (2007) 1.29
Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J Biol Chem (1992) 1.28
New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J (2000) 1.22
Very low arylsulfatase A and cerebroside sulfatase activities in leukocytes of healthy members of metachromatic leukodystrophy family. Am J Hum Genet (1977) 1.21
Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr (1989) 1.20
Leukodystrophy incidence in Germany. Am J Med Genet (1997) 1.12
Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci (1991) 1.12
Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. J Inherit Metab Dis (2001) 1.11
Long-term expression and transfer of arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vector. Gene Ther (2000) 1.11
Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J Biol Chem (1991) 1.10
Niemann-Pick disease type C. Study on the nature of the cerebral storage process. Acta Neuropathol (1985) 1.06
Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation). J Pathol (1999) 1.05
The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. Oncogene (2001) 1.04
Early-lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group. Eur J Pediatr (1998) 1.04
Saposins (sap) A and C activate the degradation of galactosylceramide in living cells. FEBS Lett (1997) 1.03
Cardiac manifestations in Fabry disease. J Inherit Metab Dis (2001) 1.02
A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet (2001) 1.02
Reoperation for fibrinous stenosis of disc mitral valve prosthesis. J Thorac Cardiovasc Surg (1969) 1.01
Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol (1997) 1.01
Accidental hypothermia. Pharmacol Ther (1983) 1.00
Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepatol (2000) 1.00
Influence of the menstrual cycle and of menopause on the gastric emptying rate of solids in female volunteers. Eur J Nucl Med (1993) 0.99
Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G. Am J Hum Genet (2000) 0.99
Hyperacute rejection of a transplanted human heart. Transplantation (1981) 0.98
Peroxisomal assembly defects: clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J Pediatr (1995) 0.98
Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue. FEBS Lett (1998) 0.96
Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study. Eur J Pediatr (1991) 0.96
Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies. Clin Chim Acta (1997) 0.95
Echocardiographic determination of mitral disc valve excursion. Circulation (1973) 0.93
Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol (1998) 0.93
Testis - a novel storage site in human cholesteryl ester storage disease. Autopsy report of an adult case with a long-standing subclinical course complicated by accelerated atherosclerosis and liver carcinoma. Virchows Arch (2000) 0.93
In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet (1990) 0.93
Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity. J Nucl Med (1995) 0.92
Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo. Biochem Biophys Res Commun (1994) 0.92
Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med (1988) 0.92
Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr (1997) 0.91
Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. J Clin Endocrinol Metab (1998) 0.91
Neurovisceral lipidosis compatible with Niemann-Pick disease type C: morphological and biochemical studies of a late infantile case and enzyme and lipid assays in a prenatal case of the same family. Acta Neuropathol (1978) 0.91
Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles. Blood Cells Mol Dis (2000) 0.91
Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria. Hum Genet (1986) 0.90
Determination of urinary sulfatides and other lipids by combination of reversed-phase and thin-layer chromatographies. Anal Biochem (1999) 0.90
Patent ductus arteriosus ligation and respiratory distress syndrome in premature infants. Ann Thorac Surg (1976) 0.89
Very long-chain fatty acids in peroxisomal disease. Adv Exp Med Biol (1992) 0.88
[Clinical and histological diagnosis of a case of familial adult metachromatic leucodystrophy (author's transl)]. J Neurol (1974) 0.88
[Niemann-Pick disease type B: An enzymatically confirmed case with unexpected retinal involvement (author's transl)]. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 0.88
Ultrastructural pathology of skin biopsy and fibroblast enzyme studies in a case of GM2-gangliosidosis with deficient hexosaminidase A and thermolabile hexosaminidase B. Neuropadiatrie (1980) 0.88
Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients. J Inherit Metab Dis (2008) 0.87
A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype. Hum Genet (1999) 0.87
[Detection and determination of parathion and p-nitrophenol in biological material by reverse-phase-high-power-liquid chromatography (author's transl)]. Arch Toxicol (1975) 0.86
False aneurysm after ligation of a patent ductus arteriosus. Ann Thorac Surg (1967) 0.86
[Ultrasound echogenic splenic tumors: nodular manifestation of type C Niemann-Pick disease]. Ultraschall Med (1990) 0.86
Morquio syndrome (mucopolysaccharidosis IV B) associated with beta-galactosidase deficiency. Report of two cases. Am J Hum Genet (1980) 0.86
Familial lysosomal storage disease with generalized vacuolization and sialic aciduria. Sporadic Salla disease. Neuropediatrics (1985) 0.86
Immunosuppressive therapy in the management of homo- and heterografted cardiac valves. Transplantation (1967) 0.86
Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells. J Neurol Sci (1995) 0.86
Prenatal diagnosis of globoid cell leukodystrophy (Krabbe's diseases). Third documented case. Hum Genet (1977) 0.86
Aortic valve replacement with the De Bakey valve. J Thorac Cardiovasc Surg (1976) 0.85
Natural history of the respiratory involvement in Anderson-Fabry disease. J Inherit Metab Dis (2007) 0.85
Riboflavin-responsive epilepsy in a patient with SER209 variant form of short-chain acyl-CoA dehydrogenase. J Inherit Metab Dis (1995) 0.85
Advantages of the Beall valve prosthesis. Chest (1971) 0.84
Age-dependent variations of the human N-acetyl- -D-hexosaminidases. J Neurochem (1971) 0.84
Genomic structure and identification of 11 novel mutations of the PEX6 (peroxisome assembly factor-2) gene in patients with peroxisome biogenesis disorders. Hum Mutat (1999) 0.84
[Prenatal diagnosis of globoid-cell leukodystrophy (Krabbe's disease) (author's transl)]. Dtsch Med Wochenschr (1976) 0.84
A case of combined Farber and Sandhoff disease. Eur J Pediatr (1989) 0.83
Pulmonary storage with emphysema as a sign of Niemann-Pick type C2 disease (second complementation group). Report of a case. Virchows Arch (2001) 0.83
Niemann-Pick disease. Analysis of liver tissue in sphingomyelinase-deficient patients. Virchows Arch A Pathol Anat Histol (1980) 0.83
Deficient ferritin immunoreactivity in tissues from niemann-pick type C patients: extension of findings to fetal tissues, H and L ferritin isoforms, but also one case of the rare Niemann-Pick C2 complementation group. Mol Genet Metab (2000) 0.83
Congenital aortic stenosis: ten to 22 years after valvulotomy. Arch Surg (1978) 0.83
Clinical presentation of pediatric multiple sclerosis before puberty. Eur J Neurol (2013) 0.82
Niemann-Pick disease type C with enhanced glycolipid storage. Report on further case of so-called lactosylceramidosis. Virchows Arch A Pathol Anat Histopathol (1984) 0.82
[Densitometric microdetermination of gangliosides from total lipid extract following thin layer chromatography]. Hoppe Seylers Z Physiol Chem (1968) 0.82
Histochemical detection of GM1 ganglioside using cholera toxin-B subunit. Evaluation of critical factors optimal for in situ detection with special emphasis to acetone pre-extraction. Eur J Histochem (2010) 0.82
Heterotransplantation of the aortic valve into the descending aorta. Arch Surg (1967) 0.82
Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process. J Inherit Metab Dis (2009) 0.82